{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:38:09Z","timestamp":1777901889630,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023968","name":"NHS Grampian","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000294","name":"Medical Research Scotland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajo.2024.07.012","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:32:22Z","timestamp":1721435542000},"page":"29-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models\u2014A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"268","author":[{"given":"Maria Anna","family":"Bantounou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulika A.K.","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josip","family":"Plascevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mintu","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyo K","family":"Myint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-211X","authenticated-orcid":false,"given":"Sam","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2024.07.012_bib0001","unstructured":"World Health Organization. Diabetic retinopathy screening: a short guide. Increase effectiveness, maximize benefits and minimize harm; 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/336660. Accessed August 20, 2023."},{"issue":"8","key":"10.1016\/j.ajo.2024.07.012_bib0002","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"9735","key":"10.1016\/j.ajo.2024.07.012_bib0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"8295","key":"10.1016\/j.ajo.2024.07.012_bib0004","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(82)90464-0","article-title":"Worsening of diabetic retinopathy with strict control of blood sugar","volume":"320","author":"Hooymans","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40261-021-01110-w","article-title":"Semaglutide and diabetic retinopathy risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"42","author":"Wang","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajo.2024.07.012_bib0006","unstructured":"Taylor R. Update on semaglutide risks. EyeNet Magazine. https:\/\/www.aao.org\/eyenet\/article\/update-on-semaglutide-risks. Accessed August 20, 2023."},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1746-1596-9-130","article-title":"Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies","volume":"9","author":"Zhao","year":"2014","journal-title":"Diagn Pathol"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.012_bib0009","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41433-019-0494-z","article-title":"New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy","volume":"33","author":"Saw","year":"2019","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.012_bib0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00006982-200605000-00011","article-title":"Diabetic macular edema associated with glitazone use","volume":"26","author":"Ryan","year":"2006","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.012_bib0011","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/dom.13232","article-title":"Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis","volume":"20","author":"Tang","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.012_bib0012","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"issue":"9739","key":"10.1016\/j.ajo.2024.07.012_bib0013","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajo.2024.07.012_bib0016","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0017","first-page":"CD009122","article-title":"Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus","volume":"2016","author":"Fullerton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2009.189","article-title":"Diabetic retinopathy and blockade of the renin\u2013angiotensin system: new data from the DIRECT study programme","volume":"24","author":"Wright","year":"2010","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.012_bib0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1742-1241.2010.02552.x","article-title":"Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review","volume":"65","author":"Sj\u00f8lie","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0021","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00125-020-05134-3","article-title":"Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting","volume":"63","author":"van der Heijden","year":"2020","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.012_bib0023","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajo.2024.07.012_bib0026","unstructured":"Cochrane. GRADE approach. https:\/\/training.cochrane.org\/grade-approach. Accessed January 23, 2023."},{"key":"10.1016\/j.ajo.2024.07.012_bib0027","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed August 20, 2023."},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0028","first-page":"MR000034","article-title":"Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials","volume":"2014","author":"Anglemyer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2024.07.012_bib0029","unstructured":"Faria R, Hernandez Alava M, Manca A, Wailoo AJ. NICE DSU technical support document 17. The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data. Decision Support Unit, University of Sheffield. May 2015. https:\/\/www.sheffield.ac.uk\/sites\/default\/files\/2022-02\/TSD17-DSU-Observational-data-FINAL.pdf. Accessed August 20, 2023."},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40264-018-0751-2","article-title":"Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis","volume":"42","author":"Gorelik","year":"2019","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.012_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2020.12.019","article-title":"Antihypertensive medication classes and the risk of dementia: a systematic review and network meta-analysis","volume":"22","author":"den Brok","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ajo.2024.07.012_bib0032","unstructured":"Salanti G, Efthimiou O. Combining randomised and non-randomised evidence in network meta-analysis (NMA). Cochrane Train 2016. https:\/\/training.cochrane.org\/resource\/combining-randomised-and-non-randomised-evidence-network-meta-analysis-nma. Accessed August 20, 2023."},{"issue":"8","key":"10.1016\/j.ajo.2024.07.012_bib0033","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/sim.7223","article-title":"Combining randomized and non-randomized evidence in network meta-analysis","volume":"36","author":"Efthimiou","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.ajo.2024.07.012_sbref0034","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.ajo.2024.07.012_bib0035","unstructured":"A Damen. Example script to perform a meta-analysis of c-statistic. https:\/\/methods.cochrane.org\/sites\/methods.cochrane.org.prognosis\/files\/uploads\/r_script_meta-analysis_c-statistic.txt . Accessed January 23, 2023."},{"key":"10.1016\/j.ajo.2024.07.012_bib0036","first-page":"1","article-title":"Deep personal multitask prediction of diabetes complication with attentive interactions predicting diabetes complications by multitask-learning","volume":"2022","author":"Zuo","year":"2022","journal-title":"J Healthc Eng"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.012_bib0037","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00592-022-01897-w","article-title":"Subclinical atherosclerosis associates with diabetic retinopathy incidence: a prospective study","volume":"59","author":"Fang","year":"2022","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.012_bib0038","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00592-022-01901-3","article-title":"Nomogram-based prediction of clinically significant macular edema in diabetes mellitus patients","volume":"59","author":"Li","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajo.2024.07.012_bib0039","doi-asserted-by":"crossref","first-page":"876559","DOI":"10.3389\/fendo.2022.876559","article-title":"Using machine learning techniques to develop risk prediction models for the risk of incident diabetic retinopathy among patients with type 2 diabetes mellitus: a cohort study","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0040","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1038\/s41598-022-12369-0","article-title":"Long-term prediction models for vision-threatening diabetic retinopathy using medical features from data warehouse","volume":"12","author":"Jo","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0041","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2589-7500(20)30250-8","article-title":"Predicting the risk of developing diabetic retinopathy using deep learning","volume":"3","author":"Bora","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0042","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/tmj.2017.0282","article-title":"A clinical decision support system for diabetic retinopathy screening: creating a clinical support application","volume":"25","author":"Romero-Aroca","year":"2019","journal-title":"Telemed J E Health"},{"issue":"02","key":"10.1016\/j.ajo.2024.07.012_bib0043","article-title":"Predicting retinopathy risk among diabetic patients: a data mining approach","volume":"31","author":"Foshati","year":"2019","journal-title":"Biomed Eng (Singapore)"},{"issue":"S9","key":"10.1016\/j.ajo.2024.07.012_bib0044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12859-018-2277-0","article-title":"Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms","volume":"19","author":"Tsao","year":"2018","journal-title":"BMC Bioinform"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0045","doi-asserted-by":"crossref","first-page":"11757","DOI":"10.1038\/s41598-017-11906-6","article-title":"Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.ajo.2024.07.012_bib0046","first-page":"472","article-title":"Predictive models for diabetic retinopathy from non-image teleretinal screening data","volume":"2019","author":"Ogunyemi","year":"2019","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0047","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.10.3.17","article-title":"Validation of a diagnostic support system for diabetic retinopathy based on clinical parameters","volume":"10","author":"Romero-Aroca","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0048","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc12-0790","article-title":"Predicting development of proliferative diabetic retinopathy","volume":"36","author":"Harris Nwanyanwu","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.012_bib0049","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jdiacomp.2010.12.002","article-title":"Predicting the risk of diabetic retinopathy in type 2 diabetic patients","volume":"25","author":"Semeraro","year":"2011","journal-title":"J Diabetes Complicat"},{"issue":"11","key":"10.1016\/j.ajo.2024.07.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108313","article-title":"Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: a retrospective study","volume":"36","author":"Yang","year":"2022","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.ajo.2024.07.012_bib0051","doi-asserted-by":"crossref","first-page":"1033611","DOI":"10.3389\/fendo.2022.1033611","article-title":"Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.012_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100276","article-title":"Developing and validating models to predict progression to proliferative diabetic retinopathy","volume":"3","author":"Guo","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajo.2024.07.012_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2023.101285","article-title":"Retinopathy prediction in type 2 diabetes: time-varying Cox proportional hazards and machine learning models","volume":"40","author":"Looareesuwan","year":"2023","journal-title":"Inform Med Unlocked"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0054","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12886-023-02925-1","article-title":"Dynamic nomogram prediction model for diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.012_bib0055","doi-asserted-by":"crossref","first-page":"e42181","DOI":"10.2196\/42181","article-title":"Machine learning for predicting micro- and macrovascular complications in individuals with prediabetes or diabetes: retrospective cohort study","volume":"25","author":"Schallmoser","year":"2023","journal-title":"J Med Internet Res"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0056","doi-asserted-by":"crossref","first-page":"ooab066","DOI":"10.1093\/jamiaopen\/ooab066","article-title":"Detecting diabetic retinopathy through machine learning on electronic health record data from an urban, safety net healthcare system","volume":"4","author":"Ogunyemi","year":"2021","journal-title":"JAMIA Open"},{"issue":"23","key":"10.1016\/j.ajo.2024.07.012_bib0057","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/sim.4780142308","article-title":"Using a mixture model to predict the occurrence of diabetic retinopathy","volume":"14","author":"Young","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.ajo.2024.07.012_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101578","article-title":"Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings","volume":"51","author":"Nugawela","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajo.2024.07.012_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109835","article-title":"Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: a FIELD substudy","volume":"186","author":"Rao","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.012_bib0064","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.012_bib0060","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/diagnostics13122084","article-title":"Machine learning-based diagnosis and ranking of risk factors for diabetic retinopathy in population-based studies from South India","volume":"13","author":"Vyas","year":"2023","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.ajo.2024.07.012_bib0061","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3390\/diagnostics13111858","article-title":"Prediction of diabetic macular edema using knowledge graph","volume":"13","author":"Li","year":"2023","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0058","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/07853890.2013.878977","article-title":"The performance of a diabetic retinopathy risk score for screening for diabetic retinopathy in Chinese overweight\/obese patients with type 2 diabetes mellitus","volume":"46","author":"Wang","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.ajo.2024.07.012_bib0059","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1472-6947-13-106","article-title":"Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study","volume":"13","author":"Oh","year":"2013","journal-title":"BMC Med Inform Decis Mak"},{"issue":"9600","key":"10.1016\/j.ajo.2024.07.012_bib0092","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.012_bib0065","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archopht.116.7.874","article-title":"Early worsening of diabetic retinopathy in the diabetes control and complications trial","volume":"116","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.012_bib0066","doi-asserted-by":"crossref","first-page":"929","DOI":"10.12659\/MSM.892056","article-title":"Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies","volume":"21","author":"Zhang","year":"2015","journal-title":"Med Sci Monitor"},{"key":"10.1016\/j.ajo.2024.07.012_bib0068","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211040109","article-title":"Effect of statin therapy on diabetes retinopathy in people with type 2 diabetes mellitus: a meta-analysis","volume":"27","author":"Liu","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0067","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1120672120922444","article-title":"Statin reduces the incidence of diabetic retinopathy and its need for intervention: a systematic review and meta-analysis","volume":"31","author":"Pranata","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0069","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2018.6399","article-title":"Association of statin therapy with prevention of vision-threatening diabetic retinopathy","volume":"137","author":"Kang","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.012_bib0070","first-page":"367","article-title":"The use of fenofibrate in the management of patients with diabetic retinopathy: an evidence-based review","volume":"44","author":"Sharma","year":"2015","journal-title":"Aust Fam Physician"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.012_bib0071","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/eye.2011.62","article-title":"Medical management of diabetic retinopathy: fenofibrate and ACCORD eye studies","volume":"25","author":"Wright","year":"2011","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.012_bib0072","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11892-016-0786-7","article-title":"Fenofibrate and diabetic retinopathy","volume":"16","author":"Knickelbein","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.012_bib0073","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41433-018-0322-x","article-title":"Prognostic prediction models for diabetic retinopathy progression: a systematic review","volume":"33","author":"Haider","year":"2019","journal-title":"Eye"},{"issue":"374","key":"10.1016\/j.ajo.2024.07.012_bib0074","doi-asserted-by":"crossref","first-page":"n2134","DOI":"10.1136\/bmj.n2134","article-title":"Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study","volume":"28","author":"Slieker","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/dc19-1897","article-title":"Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts","volume":"43","author":"Jiang","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajo.2024.07.012_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109089","article-title":"Cardiovascular risk in patients with type 2 diabetes: a systematic review of prediction models","volume":"184","author":"Galbete","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.012_bib0077","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/heartjnl-2011-300734","article-title":"Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review","volume":"98","author":"van Dieren","year":"2012","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.012_bib0078","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-021-05448-w","article-title":"Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study","volume":"64","author":"Beulens","year":"2021","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.012_bib0079","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024833","article-title":"Clinical prediction models for heart failure hospitalization in type 2 diabetes: a systematic review and meta-analysis","volume":"11","author":"Razaghizad","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.012_bib0080","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pds.4295","article-title":"Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1.0","volume":"26","author":"Wang","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1-2","key":"10.1016\/j.ajo.2024.07.012_bib0081","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/sim.4780070126","article-title":"Effects of mismodelling and mismeasuring explanatory variables on tests of their association with a response variable","volume":"7","author":"Lagakos","year":"1988","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0082","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1741-7015-9-103","article-title":"Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting","volume":"9","author":"Collins","year":"2011","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0083","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.22374\/1710-6222.25.1.4","article-title":"Impact of drug exposure definitions on observed associations in pharmacoepidemiology research","volume":"25","author":"Eskin","year":"2018","journal-title":"J Populat Ther Clin Pharmacol"},{"key":"10.1016\/j.ajo.2024.07.012_bib0084","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"issue":"356","key":"10.1016\/j.ajo.2024.07.012_bib0085","doi-asserted-by":"crossref","first-page":"i6460","DOI":"10.1136\/bmj.i6460","article-title":"A guide to systematic review and meta-analysis of prediction model performance","volume":"5","author":"Debray","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.012_bib0086","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10928-023-09850-2","article-title":"A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development","volume":"50","author":"Ruiz-Garcia","year":"2023","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0087","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0962280217720947","article-title":"Competing risks modeling of cumulative effects of time-varying drug exposures","volume":"28","author":"Danieli","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.012_bib0088","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41598-023-28393-7","article-title":"Comparing machine learning approaches to incorporate time-varying covariates in predicting cancer survival time","volume":"13","author":"Cygu","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.012_bib0089","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pds.4372","article-title":"Methods for time-varying exposure related problems in pharmacoepidemiology: an overview","volume":"27","author":"Pazzagli","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.012_bib0090","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/pds.4327","article-title":"Modelling cumulative exposure for inference about drug effects in observational studies","volume":"26","author":"Farran","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.012_bib0091","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jclinepi.2005.01.021","article-title":"Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries","volume":"59","author":"Abrahamowicz","year":"2006","journal-title":"J Clin Epidemiol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:34:23Z","timestamp":1732642463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":92,"alternative-id":["S0002939424003131"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models\u2014A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}